The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study of venetoclax combined with a 10-day regimen of decitabine in subjects with high-risk acute myeloid leukemia.
 
Rafael Madero Marroquin
No Relationships to Disclose
 
Rebecca Abraham
No Relationships to Disclose
 
Anand Patel
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Cycle Pharma; Geron; Jazz Pharmaceuticals; Novartis; SOBI; Syndax
Research Funding - Incyte (Inst); Pfizer (Inst); SERVIER (Inst); Sumitomo Dainippon Pharma Oncology (Inst)
 
Thao Trang Nguyen
No Relationships to Disclose
 
Kristen Pettit
Consulting or Advisory Role - AbbVie; Merck; Takeda
Research Funding - Abbvie (Inst); Ajax (Inst); Blueprint Medicines (Inst); Janssen (Inst); Kartos Therapeutics (Inst); Kura Oncology (Inst); Merck (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Merck
 
William Donnelly
No Relationships to Disclose
 
Howard Weiner
No Relationships to Disclose
 
Noreen Fulton
No Relationships to Disclose
 
Caner Saygin
No Relationships to Disclose
 
Mariam Nawas
No Relationships to Disclose
 
Adam DuVall
Speakers' Bureau - CE Concepts
 
Michael Drazer
Honoraria - American Society of Hematology Self-Assessment Program; Novartis
Consulting or Advisory Role - Argenx
 
Satyajit Kosuri
No Relationships to Disclose
 
Michael Thirman
No Relationships to Disclose
 
Richard Larson
No Relationships to Disclose
 
Wendy Stock
Honoraria - Adaptive Biotechnologies; Newave Pharmaceutical; servier
Consulting or Advisory Role - AstraZeneca; Jazz Pharmaceuticals; Kura Oncology; Newave Pharmaceutical; Pfizer; SERVIER
Research Funding - Kura Oncology
Patents, Royalties, Other Intellectual Property - Royalties for a chapter in Up to Date
Travel, Accommodations, Expenses - Pfizer
 
James LaBelle
No Relationships to Disclose
 
Olatoyosi Odenike
Consulting or Advisory Role - Abbvie; Geron; Rigel; SERVIER; Threadwell therapeutics
Research Funding - Abbvie (Inst); Agios (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Incyte (Inst); Kartos Therapeutics (Inst); Loxo (Inst); Servier (Inst)